An engineered enzyme that targets circulating lactate to alleviate intracellular NADH:NAD+ imbalance
- 13 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 38 (3), 309-313
- https://doi.org/10.1038/s41587-019-0377-7
Abstract
An elevated intracellular NADH:NAD+ ratio, or ‘reductive stress’, has been associated with multiple diseases, including disorders of the mitochondrial electron transport chain. As the intracellular NADH:NAD+ ratio can be in near equilibrium with the circulating lactate:pyruvate ratio, we hypothesized that reductive stress could be alleviated by oxidizing extracellular lactate to pyruvate. We engineered LOXCAT, a fusion of bacterial lactate oxidase (LOX) and catalase (CAT), which irreversibly converts lactate and oxygen to pyruvate and water. Addition of purified LOXCAT to the medium of cultured human cells with a defective electron transport chain decreased the extracellular lactate:pyruvate ratio, normalized the intracellular NADH:NAD+ ratio, upregulated glycolytic ATP production and restored cellular proliferation. In mice, tail-vein-injected LOXCAT lowered the circulating lactate:pyruvate ratio, blunted a metformin-induced rise in blood lactate:pyruvate ratio and improved NADH:NAD+ balance in the heart and brain. Our study lays the groundwork for a class of injectable therapeutic enzymes that alleviates intracellular redox imbalances by directly targeting circulating redox-coupled metabolites.Keywords
Funding Information
- Howard Hughes Medical Institute (Investigator Award)
- U.S. Department of Health & Human Services | National Institutes of Health (R35GM122455)
- Marriott Foundation
This publication has 35 references indexed in Scilit:
- Imaging Cytosolic NADH-NAD+ Redox State with a Genetically Encoded Fluorescent BiosensorCell Metabolism, 2011
- A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cellsProceedings of the National Academy of Sciences of the United States of America, 2010
- Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-βAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Crystallographic study on the interaction of l-lactate oxidase with pyruvate at 1.9Å resolutionBiochemical and Biophysical Research Communications, 2007
- The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin"Protein Engineering, Design and Selection", 2006
- Rebuilt AAA + motors reveal operating principles for ATP-fuelled machinesNature, 2005
- Use of ?-asparaginase in childhood ALLCritical Reviews in Oncology/Hematology, 1998
- Human Cells Lacking mtDNA: Repopulation with Exogenous Mitochondria by ComplementationScience, 1989
- Thrombolytic TherapyThe New England Journal of Medicine, 1984
- State of Oxidation-Reduction and State of Binding in the Cytosolic NADH-System as Disclosed by Equilibration with Extracellular Lactate/Pyruvate in Hemoglobin-Free Perfused Rat LiverJBIC Journal of Biological Inorganic Chemistry, 1972